Organometallic ruthenium-based antitumor compounds with novel modes of action

Keyphrases

• Ruthenium Complexes 100%
• RAPTA 100%
• Antitumor Compounds 100%
• Novel Mode of Action 100%
• Organometallic Compounds 66%
• Tumor Targeting 66%
• Chloride 33%
• Metal Complexes 33%
• Cisplatin 33%
• Arenes 33%
• Organic Matter 33%
• Linker 33%
• Unique Properties 33%
• Radiotherapy 33%
• Organic Molecules 33%
• Anticancer Drugs 33%
• Tumor Subtype 33%
• Human Serum Albumin 33%
• Inorganic Materials 33%
• Organic Structure 33%
• Physicochemical Properties 33%
• Medicinal Chemistry 33%
• Drug Action 33%
• Complex Molecules 33%
• Activity in Vivo 33%
• Hydrolysable 33%
• Targeted Therapy 33%
• Drug Resistance 33%
• Specific Enzymes 33%
• Strategies to Overcome 33%
• Anticancer Agents 33%
• Rational Drug Design 33%
• Arene-ruthenium(II) Complexes 33%
• Anti-metastatic Activity 33%
• Metal-based Drugs 33%
• Physiological Environment 33%
• Pharmacological Properties 33%
• Physiological Studies 33%
• Aquation 33%
• Direct Substitution 33%
• Hybrid Compounds 33%
• Personalized Chemotherapy 33%
• Deactivation 33%
• Critical Enzymes 33%
• Metal-organic 33%
• Treat Cancer 33%
• Biomolecular Targets 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Anticarcinogen 100%
• Organometallic Compound 100%
• Neoplasm 100%
• Enzymes 100%
• Polycyclic Aromatic Hydrocarbon 100%
• Diseases 100%
• Mode of Action 100%
• Pharmaceutical Chemistry 50%
• Drug Development 50%
• Cisplatin 50%
• Chemotherapy Regimens 50%
• Human Serum Albumin 50%
• Chloride 50%
• Metal Complex 50%
• Metastasis Inhibition 50%
• Drug Resistance 50%
• Pirenzepine 50%

Chemistry

• Metallocene 100%
• Ruthenium 100%
• Antineoplastic Agent 100%
• Antitumor 100%
• Organometallic Compound 100%
• Chemistry 50%
• Deoxyribonucleic Acid 50%
• Organic Molecule 50%
• Antimetastatic 50%
• Pharmacological Property 50%
• Cisplatin 50%
• Chloride 50%
• Albumin 50%
• Organic Material 50%